Zisen Lai

Jintang Road 66
Fuzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

A deep learning model to predict objective response to TACE and TKI-based therapy in HBV-related uHCC.

A deep learning model to predict objective response to TACE and TKI-based therapy in HBV-related uHCC.

Journal: Scientific reports

Published: May 18, 2026

Tailoring nanovectors for optimal neoantigen vaccine efficacy.

Tailoring nanovectors for optimal neoantigen vaccine efficacy.

Journal: Journal of materials chemistry. B

Published: March 05, 2025

Tumor suppressor OSR1 is modified by SUMO1 and regulates the Wnt/β-catenin signaling pathway in HCC.

Tumor suppressor OSR1 is modified by SUMO1 and regulates the Wnt/β-catenin signaling pathway in HCC.

Journal: Experimental cell research

Published: June 16, 2024

Resection Margin Width Does Not Influence the Prognosis of Solitary Hepatocellular Carcinoma After Anatomic Resection: A Real-World Study from China.

Resection Margin Width Does Not Influence the Prognosis of Solitary Hepatocellular Carcinoma After Anatomic Resection: A Real-World Study from China.

Journal: Journal of hepatocellular carcinoma

Published: May 25, 2023

Natural killer cells modified with a Gpc3 aptamer enhance adoptive immunotherapy for hepatocellular carcinoma.

Natural killer cells modified with a Gpc3 aptamer enhance adoptive immunotherapy for hepatocellular carcinoma.

Journal: Discover oncology

Published: April 10, 2023

A novel preoperative inflammation score system established for postoperative prognosis predicting of intrahepatic cholangiocarcinoma.

A novel preoperative inflammation score system established for postoperative prognosis predicting of intrahepatic cholangiocarcinoma.

Journal: BMC cancer

Published: December 11, 2021

Postoperative Adjuvant Transarterial Chemoembolization Plus Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma: a Multicentre Retrospective Study.

Postoperative Adjuvant Transarterial Chemoembolization Plus Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma: a Multicentre Retrospective Study.

Journal: Journal of hepatocellular carcinoma

Published: December 04, 2021

Redirecting natural killer cells to potentiate adoptive immunotherapy in solid tumors through stabilized Y-type bispecific aptamer.

Redirecting natural killer cells to potentiate adoptive immunotherapy in solid tumors through stabilized Y-type bispecific aptamer.

Journal: Nanoscale

Published: June 22, 2021

Showing 1-8 of 8

Last Updated: 09/26/2026